|
Strides Pharma Science Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
11482.88 Cr.
|
P/BV
|
3.51
|
Book Value (Rs.)
|
355.24
|
|
52 Week High/Low (Rs.)
|
1231/769
|
FV/ML
|
10/1
|
P/E(X)
|
20.65
|
|
Bookclosure
|
31/07/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.40
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4627.97 | 4391.68 | 3891.02 | 3607.67 | 3022.06 |
| Other Operating Revenues | 230.72 | 173.65 | 160.10 | 80.72 | 48.19 |
| Total Operating Revenues | 4858.68 | 4565.34 | 4051.12 | 3688.39 | 3070.25 |
| | | | | | |
| Other Income | 150.71 | 58.72 | 39.70 | 90.33 | 131.99 |
| Total Revenue | 5009.40 | 4624.06 | 4090.83 | 3778.72 | 3202.24 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1558.92 | 1475.89 | 1341.11 | 1441.68 | 1090.93 |
| Purchase Of Stock-In Trade | 361.54 | 688.08 | 283.45 | 187.87 | 316.11 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 38.28 | -184.01 | 15.94 | -2.67 | 95.28 |
| Employee Benefit Expenses | 928.96 | 862.76 | 751.13 | 732.02 | 646.91 |
| Finance Costs | 178.55 | 248.85 | 314.45 | 261.14 | 176.74 |
| Depreciation And Amortisation Expenses | 202.40 | 192.26 | 220.68 | 243.25 | 233.01 |
| Other Expenses | 1045.70 | 919.80 | 916.23 | 899.30 | 941.13 |
| Total Expenses | 4314.34 | 4203.63 | 3842.99 | 3762.60 | 3500.11 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 695.06 | 420.42 | 247.84 | 16.12 | -297.88 |
| | | | | | |
| Exceptional Items | -26.84 | 64.66 | -189.05 | -17.03 | -243.83 |
| Profit/Loss Before Tax | 668.22 | 485.08 | 58.79 | -0.92 | -541.70 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 77.88 | 46.91 | 37.31 | -31.70 | -150.44 |
| Deferred Tax | 16.29 | 30.61 | -5.72 | -23.60 | -27.82 |
| Total Tax Expenses | 94.17 | 77.52 | 31.59 | -55.30 | -178.26 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 574.05 | 407.57 | 27.20 | 54.38 | -363.44 |
| | | | | | |
| Profit/Loss From Continuing Operations | 574.05 | 407.57 | 27.20 | 54.38 | -363.44 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 3188.11 | 54.22 | 18.57 | 0.00 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 3188.11 | 54.22 | 18.57 | 0.00 |
| Profit/Loss For The Period | 574.05 | 3595.68 | 81.42 | 72.95 | -363.44 |
| | | | | | |
| Minority Interest | -18.33 | -4.06 | 23.70 | 9.70 | 14.04 |
| Share Of Profit/Loss Of Associates | 0.47 | 1.84 | -175.74 | -285.28 | -110.81 |
| Consolidated Profit/Loss After MI And Associates | 556.19 | 3593.46 | -70.61 | -202.64 | -460.21 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 60.34 | 390.55 | -7.76 | -22.49 | -51.28 |
| Diluted EPS (Rs.) | 60.34 | 390.50 | -7.76 | -22.49 | -51.28 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 36.87 | 22.99 | 13.55 | 0.00 | 0.00 |
